添加微信 添加微信
添加微信
首页: 全球医药政策

印度-Divi's Laboratories Limited

时间:2021-10-21 16:36:55 来源:康安医药咨询 作者:康安医药咨询

Divi’s has been established for more than 29 years in Hyderabad, India with two manufacturing units and is among the top pharmaceuticals companies in India. Divi’s is recognized as a ‘Reliable Supplier of generic APIs (Active pharmaceuticals ingredients)’ and a trustworthy ‘Custom Manufacturer’ to Big Pharma and also is among the top API manufactures in the world. Divi’s is the leading manufacturer of APIs(Active pharmaceuticals ingredients), Intermediates and Registered starting materials offering high quality products with the highest level of compliance and integrity to over 95 countries. Divi’s recently reached the milestone of being one among the top 3 API manufacturers in the world and one among the top API companies in Hyderabad 11,000 highly trained professionals across departments and 350 scientists at Divi’s work together to bring world class products to customers. Divi’s is a Public limited company listed on the Indian stock exchange with a revenue of INR 5036 crores (~$730M) for the year 2018-19.Advanced manufacturing facilities both in Hyderabad and Vizag have been inspected multiple times by USFDA, EU GMP (UK, Slovenia, German, Irish authorities), HEALTH CANADA, TGA, ANVISA , COFEPRIS, PMDA and MFDS health authorities.

Phone: +91, (40), 2378, 6300 Fax: 91, (40), 2378, 6460
Web: http://www.divislabs.com
Add:1-72/23(P)/DIVIS/303, Divi Towers, Cyber Hills, Gachibowli, Hyderabad, Telangana, India – 500 032.

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章